Literature DB >> 6875728

Phototherapy for neonatal jaundice: optimal wavelengths of light.

J F Ennever, A F McDonagh, W T Speck.   

Abstract

Phototherapy results in transformation of bilirubin to more water-soluble isomers. The efficacy of monochromatic visible light from 350 to 550 nm in the fastest photoisomerization reaction was quantitated by high-pressure liquid chromatography. The most effective wavelengths in vitro (i.e., leading to greater than 25% photoisomer) were in the blue spectrum from approximately 390 to 470 nm. Green light (530 nm) was not only ineffective for production of photoisomer, but capable of reversing the reaction. The results indicate that any clinically useful phototherapy unit must include the blue portion of the visible spectrum, and suggest that the effectiveness of phototherapy may be increased by elimination of green light.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6875728     DOI: 10.1016/s0022-3476(83)80370-9

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  12 in total

1.  Clinical usefulness of high intensity green light phototherapy in the treatment of neonatal jaundice.

Authors:  M Amato; D Inaebnit
Journal:  Eur J Pediatr       Date:  1991-02       Impact factor: 3.183

2.  Effect of phototherapy with turquoise vs. blue LED light of equal irradiance in jaundiced neonates.

Authors:  Finn Ebbesen; Pernille K Vandborg; Poul H Madsen; Torleif Trydal; Lasse H Jakobsen; Hendrik J Vreman
Journal:  Pediatr Res       Date:  2015-10-20       Impact factor: 3.756

3.  Renal handling of bilirubin photoderivatives.

Authors:  M M Elías; E J Comin; J E Ochoa; E A Rodríguez Garay
Journal:  Experientia       Date:  1987-08-15

4.  The effect of bilirubin photoisomers on unbound-bilirubin concentrations estimated by the peroxidase method.

Authors:  S Itoh; T Yamakawa; S Onishi; K Isobe; M Manabe; K Sasaki
Journal:  Biochem J       Date:  1986-10-15       Impact factor: 3.857

5.  Phototherapy for neonatal hyperbilirubinemia and childhood eczema, rhinitis and wheeze.

Authors:  Elizabeth Huiwen Tham; Evelyn Xiu Ling Loo; Anne Goh; Oon Hoe Teoh; Fabian Yap; Kok Hian Tan; Keith M Godfrey; Hugo Van Bever; Bee Wah Lee; Yap Seng Chong; Lynette Pei-Chi Shek
Journal:  Pediatr Neonatol       Date:  2018-03-24       Impact factor: 2.083

6.  Action spectrum of phototherapy in hyperbilirubinemic neonates.

Authors:  Finn Ebbesen; Mette L Donneborg; Pernille K Vandborg; Hendrik J Vreman
Journal:  Pediatr Res       Date:  2021-11-17       Impact factor: 3.953

7.  Comparison of kinetic study of the photochemical changes of (ZZ)-bilirubin IX alpha bound to human serum albumin with that bound to rat serum albumin.

Authors:  S Onishi; S Itoh; T Yamakawa; K Isobe; M Manabe; S Toyota; T Imai
Journal:  Biochem J       Date:  1985-09-15       Impact factor: 3.857

8.  In vitro and in vivo efficacy of new blue light emitting diode phototherapy compared to conventional halogen quartz phototherapy for neonatal jaundice.

Authors:  Yun Sil Chang; Jong Hee Hwang; Hyuk Nam Kwon; Chang Won Choi; Sun Young Ko; Won Soon Park; Son Moon Shin; Munhyang Lee
Journal:  J Korean Med Sci       Date:  2005-02       Impact factor: 2.153

9.  Data in support of effect of blue LED irradiation in human lymphoma cells.

Authors:  Phil-Sun Oh; Hyosook Hwang; Hwan-Seok Jeong; Jeongil Kwon; Hyun-Soo Kim; Minjoo Kim; SeokTae Lim; Myung-Hee Sohn; Hwan-Jeong Jeong
Journal:  Data Brief       Date:  2016-01-15

10.  Blue light inhibits the growth of B16 melanoma cells.

Authors:  Masayuki Ohara; Yuzo Kawashima; Osamu Katoh; Hiromitsu Watanabe
Journal:  Jpn J Cancer Res       Date:  2002-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.